Side-by-side comparison of AI visibility scores, market position, and capabilities
Dublin power management technology (NYSE: ETN) at record $24.9B FY2024 revenue (+7%); Electrical Americas data center switchgear/UPS demand surge, record orders and backlog, competing with Schneider Electric and ABB.
Eaton Corporation plc is a Dublin, Ireland-incorporated power management technology company — publicly traded on the New York Stock Exchange (NYSE: ETN) as an S&P 500 Industrials component — providing electrical components, systems, and services for safe, efficient, and reliable electrical power, as well as hydraulic and aerospace power management products through approximately 100,000 employees in 160+ countries. In fiscal year 2024, Eaton reported record revenues of $24.9 billion (+7% year-over-year), with exceptional performance from the Electrical Americas segment (circuit breakers, switchgear, power distribution units, UPS systems, and EV charging equipment) driven by hyperscale data center construction, utility grid modernization, and US industrial reshoring. Eaton achieved record segment margins with strong orders and backlog growth across its electrical and aerospace segments, with the company guiding continued above-average growth in 2025 as data center power infrastructure spending accelerates. CEO Craig Arnold has led Eaton since 2016, executing the strategy of concentrating Eaton's portfolio on high-growth electrical and aerospace markets — divesting the Hydraulics segment in 2021 (sold to Danfoss for $3.3 billion) and the Vehicle segment businesses to concentrate on data center power, grid infrastructure, and aerospace power systems. The Electrical Americas segment's backlog grew to record levels as hyperscaler capital expenditure commitments for AI data center infrastructure created multi-year demand visibility for electrical switchgear, power distribution, and UPS equipment.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.